Search Results - "Peacock, Linda"

Refine Results
  1. 1
  2. 2

    Effects of cannabinoid CB1 receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys by Madsen, Morten V., Peacock, Linda P., Werge, Thomas, Andersen, Maibritt B., Andreasen, Jesper T.

    Published in Neuropharmacology (01-02-2011)
    “…Antipsychotic drugs may cause extrapyramidal symptoms (EPS), such as dyskinesia and dystonia. These effects are believed to involve dysfunctional striatal…”
    Get full text
    Journal Article
  3. 3

    Aberrant behavioral effects of a dopamine D1 receptor antagonist and agonist in monkeys: evidence of uncharted dopamine D1 receptor actions by Peacock, Linda, Gerlach, Jes

    Published in Biological psychiatry (1969) (01-10-2001)
    “…Background: Basic research indicates a role for dopamine (DA) D1 antagonism in the treatment of schizophrenia. Clinical trials have not confirmed any role…”
    Get full text
    Journal Article
  4. 4

    The effects of dopamine D3 agonists and antagonists in a nonhuman primate model of tardive dyskinesia by Malik, Peter, Andersen, Maibritt B., Peacock, Linda

    Published in Pharmacology, biochemistry and behavior (01-08-2004)
    “…Tardive dyskinesia (TD), a serious complication of antipsychotic dopamine (DA) antagonist treatment, has been hypothesised to develop due to a dominant DA D1…”
    Get full text
    Journal Article
  5. 5
  6. 6

    The muscarinic M1/M4 receptor agonist xanomeline exhibits antipsychotic-like activity in Cebus apella monkeys by ANDERSEN, Maibritt B, FINK-JENSEN, Anders, PEACOCK, Linda, GERLACH, Jes, BYMASTER, Frank, LUNDBAEK, Jens August, WERGE, Thomas

    Published in Neuropsychopharmacology (New York, N.Y.) (01-06-2003)
    “…Xanomeline is a muscarinic M(1)/M(4) preferring receptor agonist with little or no affinity for dopamine receptors. The compound reduces psychotic-like…”
    Get full text
    Journal Article
  7. 7

    Pre-eclampsia and future cardiovascular disease risk: Assessing British clinicians’ knowledge and practice by Jones, Olivia, Ormesher, Laura, Duhig, Kate E., Peacock, Linda, Myers, Jenny E.

    Published in Pregnancy hypertension (01-09-2024)
    “…•This is the first study of UK clinicians’ awareness of CVD risk after pre-eclampsia.•Clinicians know pre-eclampsia increases hypertension and stroke risk.•Six…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Effects of cannabinoid CB sub(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys by Madsen, Morten V, Peacock, Linda P, Werge, Thomas, Andersen, Maibritt B, Andreasen, Jesper T

    Published in Neuropharmacology (01-03-2011)
    “…Antipsychotic drugs may cause extrapyramidal symptoms (EPS), such as dyskinesia and dystonia. These effects are believed to involve dysfunctional striatal…”
    Get full text
    Journal Article
  11. 11

    Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys by MADSEN, Morten V, PEACOCK, Linda, WERGE, Thomas, ANDERSEN, Maibritt B

    Published in Journal of psychopharmacology (Oxford) (01-09-2006)
    “…Several clinical studies have shown that alterations in the cannabinoid system in the brain may be associated with schizophrenia. Although evidence points…”
    Get full text
    Journal Article
  12. 12

    Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebusmonkeys by Madsen, Morten V., Peacock, Linda, Werge, Thomas, Andersen, Maibritt B.

    Published in Journal of psychopharmacology (Oxford) (01-09-2006)
    “…Several clinical studies have shown that alterations in the cannabinoid system in the brain may be associated with schizophrenia. Although evidence points…”
    Get full text
    Journal Article
  13. 13

    New and old antipsychotics versus clozapine in a monkey model : adverse effects and antiamphetamine effects by PEACOCK, L, GERLACH, J

    Published in Psychopharmacologia (01-06-1999)
    “…Neuroleptic primed Cebus apella monkeys have proven reliable in screening antipsychotics for extrapyramidal side effect (EPS) potential in humans, and the…”
    Get full text
    Journal Article
  14. 14

    Climatic factors and bipolar affective disorder by Margrethe Christensen, Ellen, Knud Larsen, Jens, Gjerris, Annette, Peacock, Linda, Jacobi, Marianne, Hassenbalch, Ellen

    Published in Nordic journal of psychiatry (2008)
    “…In bipolar disorder, the factors provoking a new episode are unknown. As a seasonal variation has been noticed, it has been suggested that weather conditions…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Effects of several partial dopamine D2 receptor agonists in Cebus apella monkeys previously treated with haloperidol by Peacock, L, Gerlach, J

    Published in European journal of pharmacology (24-06-1993)
    “…Eight Cebus apella monkeys were treated with haloperidol for 2 years. Five monkeys had developed mild oral tardive dyskinesia and all were primed for…”
    Get more information
    Journal Article
  17. 17

    Extrapyramidal side effects during chronic combined dopamine D1 and D2 antagonist treatment in Cebus apella monkeys by Peacock, L, Jensen, G, Nicholson, K, Gerlach, J

    “…Previous studies in non-human primates have shown that tolerance to dystonia occurs during chronic dopamine D1 (D1) but not D2 antagonism and…”
    Get full text
    Journal Article
  18. 18

    The effects of dopamine D1 and D2 receptor agonists and antagonists in monkeys withdrawn from long-term neuroleptic treatment by Peacock, L, Lublin, H, Gerlach, J

    Published in European journal of pharmacology (04-09-1990)
    “…The effects of dopamine D1 and D2 receptor agonists and antagonists were studied in eight Cebus apella monkeys previously treated with haloperidol for two…”
    Get more information
    Journal Article
  19. 19

    Chronic treatment with the D1 receptor antagonist, SCH 23390, and the D2 receptor antagonist, raclopride, in cebus monkeys withdrawn from previous haloperidol treatment : extrapyramidal syndromes and dopaminergic supersensitivity by LUBLIN, H, GERLACH, J, PEACOCK, L

    Published in Psychopharmacologia (01-09-1993)
    “…The effects of chronic treatment with dopamine (DA) D1 and D2 receptor antagonists were evaluated in eight cebus apella monkeys with mild oral dyskinesia after…”
    Get full text
    Journal Article
  20. 20

    Effect of D1 and D2 agonists in primates withdrawn from long-term treatment with haloperidol: the potential role of dopamine D1 receptors in dyskinesia by Lublin, H, Gerlach, J, Peacock, L

    Published in Clinical neuropharmacology (01-12-1992)
    “…The effects of dopamine (DA) D1 and D2 receptor agonists were evaluated in eight Cebus apella monkeys. The monkeys had previously received haloperidol for 2…”
    Get more information
    Journal Article